Cardiac fibrosis

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

(Redirected from Endocardial fibrosis)
Jump to: navigation, search

WikiDoc Resources for

Cardiac fibrosis

Articles

Most recent articles on Cardiac fibrosis

Most cited articles on Cardiac fibrosis

Review articles on Cardiac fibrosis

Articles on Cardiac fibrosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cardiac fibrosis

Images of Cardiac fibrosis

Photos of Cardiac fibrosis

Podcasts & MP3s on Cardiac fibrosis

Videos on Cardiac fibrosis

Evidence Based Medicine

Cochrane Collaboration on Cardiac fibrosis

Bandolier on Cardiac fibrosis

TRIP on Cardiac fibrosis

Clinical Trials

Ongoing Trials on Cardiac fibrosis at Clinical Trials.gov

Trial results on Cardiac fibrosis

Clinical Trials on Cardiac fibrosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cardiac fibrosis

NICE Guidance on Cardiac fibrosis

NHS PRODIGY Guidance

FDA on Cardiac fibrosis

CDC on Cardiac fibrosis

Books

Books on Cardiac fibrosis

News

Cardiac fibrosis in the news

Be alerted to news on Cardiac fibrosis

News trends on Cardiac fibrosis

Commentary

Blogs on Cardiac fibrosis

Definitions

Definitions of Cardiac fibrosis

Patient Resources / Community

Patient resources on Cardiac fibrosis

Discussion groups on Cardiac fibrosis

Patient Handouts on Cardiac fibrosis

Directions to Hospitals Treating Cardiac fibrosis

Risk calculators and risk factors for Cardiac fibrosis

Healthcare Provider Resources

Symptoms of Cardiac fibrosis

Causes & Risk Factors for Cardiac fibrosis

Diagnostic studies for Cardiac fibrosis

Treatment of Cardiac fibrosis

Continuing Medical Education (CME)

CME Programs on Cardiac fibrosis

International

Cardiac fibrosis en Espanol

Cardiac fibrosis en Francais

Businness

Cardiac fibrosis in the Marketplace

Patents on Cardiac fibrosis

Experimental / Informatics

List of terms related to Cardiac fibrosis

Cardiology Network

Discuss Cardiac fibrosis further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Cardiac fibrosis refers to an abnormal thickening of the heart valves due to inappropriate proliferation of cardiac fibroblasts.

Pathophysiology

These cells secrete collagen, and normally function to provide structural support for the heart. When over activated this process causes thickening and fibrosis, primarily on the tricuspid valve, but also occurring on the pulmonary valve, eventually leading to right-sided heart failure.

Certain diseases such as gastrointestinal carcinoid tumors, which release large amounts of serotonin into the blood, produce a characteristic pattern of mostly right sided cardiac fibrosis which can be identified at autopsy. This pathology has also been seen in certain african tribes who eat foods containing excess amounts of serotonin.

Some appetite suppressant drugs such as fenfluramine and chlorphentermine induce a similar pattern of cardiac fibrosis, by over-stimulating 5HT2B receptors on the cardiac fibroblast cells. These drugs consequently tended to cause increased risk of heart valve damage and subsequent heart failure, which eventually led to them being withdrawn from the market.

A compound found in red wine, resveratrol has been found to slow down the development of cardiac fibrosis.

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
related articles
viewed previously [ + ]